288 Harnessing the potential of transcriptional adaptation as a mechanism for Amyotrophic lateral sclerosis

por Gomez, Adriana Morales, Staff, Nathan, Ekker, Stephen C.
Publicado 2023

2018: The translational integrator: Facilitating collaboration and bridging the “Valley of Death”

por Joelle Greenberg, Alexandra, Staff, Nathan P., Windebank, Anthony
Publicado 2018

Association between ALS and retroviruses: evidence from bioinformatics analysis

por Klein, Jon P., Sun, Zhifu, Staff, Nathan P.
Publicado 2019

320 Genetic Compensation as a mechanism underlying patients with Rare ALS

por Gomez, Adriana Morales, Staff, Nathan, Ekker, Stephen C.
Publicado 2022

Skin Extracellular Matrix Breakdown Following Paclitaxel Therapy in Patients with Chemotherapy-Induced Peripheral Neuropathy

por Staff, Nathan P., Hrstka, Sybil C., Dasari, Surendra, Capobianco, Enrico, Rieger, Sandra
Publicado 2023

2219: Amyotrophic lateral sclerosis, stem cells and TALENted technology

por Kurani, Shaheen, Madigan, Nicolas, Clark, Karl, Ekker, Stephen, Staff, Nathan, Windebank, Anthony
Publicado 2018

Assessing Decreased Sensation and Increased Sensory Phenomena in Diabetic Polyneuropathies

por Dyck, Peter J., Herrmann, David N., Staff, Nathan P., Dyck, P. James B.
Publicado 2013

Biomolecular alterations detected in multiple sclerosis skin fibroblasts using Fourier transform infrared spectroscopy

por Wilkins, Jordan M., Gakh, Oleksandr, Guo, Yong, Popescu, Bogdan, Staff, Nathan P., Lucchinetti, Claudia F.
Publicado 2023

Identification of potential pathways and biomarkers linked to progression in ALS

por Huber, Roland G., Pandey, Swapnil, Chhangani, Deepak, Rincon‐Limas, Diego E., Staff, Nathan P., Yeo, Crystal Jing Jing
Publicado 2022

Clinical trials in Charcot-Marie-Tooth disorders: a retrospective and preclinical assessment

por Nair, Malavika A., Niu, Zhiyv, Madigan, Nicholas N., Shin, Alexander Y., Brault, Jeffrey S., Staff, Nathan P., Klein, Christopher J.
Publicado 2023

Brachial Plexus Neuritis Associated With Anti–Programmed Cell Death-1 Antibodies: Report of 2 Cases

por Alhammad, Reem M., Dronca, Roxanna S., Kottschade, Lisa A., Turner, Heidi J., Staff, Nathan P., Mauermann, Michelle L., Tracy, Jennifer A., Klein, Christopher J.
Publicado 2017

Comprehensive immune profiling reveals substantial immune system alterations in a subset of patients with amyotrophic lateral sclerosis

por Gustafson, Michael P., Staff, Nathan P., Bornschlegl, Svetlana, Butler, Greg W., Maas, Mary L., Kazamel, Mohamed, Zubair, Adeel, Gastineau, Dennis A., Windebank, Anthony J., Dietz, Allan B.
Publicado 2017

Lessons Learned from Clinical and Translational Science Faculty and Student Survey as COVID-19 Pandemic Continues to Shift Education Online

por Forkner, Katherine A., Wissman, Adam W., Jimison, Ryan C., Nelson, Kristina B., Wuertz, Ryan E., Silvano, Carmen J., Barreto, Erin F., Eckel Passow, Jeanette E., Enders, Felicity T., Staff, Nathan P.
Publicado 2022

Expanded neuromuscular morbidity in Hodgkin lymphoma after radiotherapy

por Oishi, Tatsuya, Kogelschatz, Cory J, Young, Nathan P, Hoffmann, Ernest M, Staff, Nathan P, Visscher, Sue L, Borah, Bijan J, Krauss, William E, Arumaithurai, Kogulavadanan, Shelly, Shahar, Ansell, Stephen M, Klein, Christopher J
Publicado 2020

Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS

por Goyal, Namita A., Berry, James D., Windebank, Anthony, Staff, Nathan P., Maragakis, Nicholas J., van den Berg, Leonard H., Genge, Angela, Miller, Robert, Baloh, Robert H., Kern, Ralph, Gothelf, Yael, Lebovits, Chaim, Cudkowicz, Merit
Publicado 2020

Toward a fully implantable ecosystem for adaptive neuromodulation in humans: Preliminary experience with the CorTec BrainInterchange device in a canine model

por Schalk, Gerwin, Worrell, Samuel, Mivalt, Filip, Belsten, Alexander, Kim, Inyong, Morris, Jonathan M., Hermes, Dora, Klassen, Bryan T., Staff, Nathan P., Messina, Steven, Kaufmann, Timothy, Rickert, Jörn, Brunner, Peter, Worrell, Gregory A., Miller, Kai J.
Publicado 2022

NurOwn, phase 2, randomized, clinical trial in patients with ALS: Safety, clinical, and biomarker results

por Berry, James D., Cudkowicz, Merit E., Windebank, Anthony J., Staff, Nathan P., Owegi, Margaret, Nicholson, Katherine, McKenna-Yasek, Diane, Levy, Yossef S., Abramov, Natalie, Kaspi, Haggai, Mehra, Munish, Aricha, Revital, Gothelf, Yael, Brown, Robert H.
Publicado 2019

Alterations of mesenchymal stromal cells in cerebrospinal fluid: insights from transcriptomics and an ALS clinical trial

por Krull, Ashley A., Setter, Deborah O., Gendron, Tania F., Hrstka, Sybil C. L., Polzin, Michael J., Hart, Joseph, Dudakovic, Amel, Madigan, Nicolas N., Dietz, Allan B., Windebank, Anthony J., van Wijnen, Andre J., Staff, Nathan P.
Publicado 2021

Dominant collagen XII mutations cause a distal myopathy

por Mohassel, Payam, Liewluck, Teerin, Hu, Ying, Ezzo, Daniel, Ogata, Tracy, Saade, Dimah, Neuhaus, Sarah, Bolduc, Véronique, Zou, Yaqun, Donkervoort, Sandra, Medne, Livija, Sumner, Charlotte J., Dyck, P. James B., Wierenga, Klaas J., Tennekoon, Gihan, Finkel, Richard S., Chen, Jiani, Winder, Thomas L., Staff, Nathan P., Foley, A. Reghan, Koch, Manuel, Bönnemann, Carsten G.
Publicado 2019

A randomized placebo‐controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis

por Cudkowicz, Merit E., Lindborg, Stacy R., Goyal, Namita A., Miller, Robert G., Burford, Matthew J., Berry, James D., Nicholson, Katharine A., Mozaffar, Tahseen, Katz, Jonathan S., Jenkins, Liberty J., Baloh, Robert H., Lewis, Richard A., Staff, Nathan P., Owegi, Margaret A., Berry, Donald A., Gothelf, Yael, Levy, Yossef S., Aricha, Revital, Kern, Ralph Z., Windebank, Anthony J., Brown, Robert H.
Publicado 2022